Open | - |
Close | - |
Volume / Avg. | 0 / 14.681K |
Day Range | - - - |
52 Wk Range | 1.860 - 9.010 |
Market Cap | $13.299M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 0.33% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Benitec Biopharma (NASDAQ: BNTC) through any online brokerage.
Other companies in Benitec Biopharma’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Benitec Biopharma (NASDAQ: BNTC) was reported by JMP Securities on Thursday, February 15, 2024. The analyst firm set a price target for 10.00 expecting BNTC to rise to within 12 months (a possible 85.19% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Benitec Biopharma (NASDAQ: BNTC) is $5.4 last updated March 20, 2024 at 9:03 AM EDT.
There are no upcoming dividends for Benitec Biopharma.
Benitec Biopharma’s Q3 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Benitec Biopharma.
Benitec Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.